Cargando…

Oxygen metabolism abnormality and Alzheimer's disease: An update

Oxygen metabolism abnormality plays a crucial role in the pathogenesis of Alzheimer's disease (AD) via several mechanisms, including hypoxia, oxidative stress, and mitochondrial dysfunction. Hypoxia condition usually results from living in a high-altitude habitat, cardiovascular and cerebrovasc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Guangdong, Yang, Cui, Wang, Xin, Chen, Xi, Wang, Yanjiang, Le, Weidong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10665957/ https://www.ncbi.nlm.nih.gov/pubmed/37956598 http://dx.doi.org/10.1016/j.redox.2023.102955

Ejemplares similares

The Crucial Roles of Pitx3 in Midbrain Dopaminergic Neuron Development and Parkinson’s Disease-Associated Neurodegeneration
por: Wang, Xin, et al.
Publicado: (2023)

The role of NURR1 in metabolic abnormalities of Parkinson’s disease
por: Al-Nusaif, Murad, et al.
Publicado: (2022)

The neuroprotective effects of oxygen therapy in Alzheimer’s disease: a narrative review
por: Yang, Cui, et al.
Publicado: (2022)

Abnormal Homocysteine Metabolism: An Insight of Alzheimer's Disease from DNA Methylation
por: Pi, Tingting, et al.
Publicado: (2020)

Advances in retina imaging as potential biomarkers for early diagnosis of Alzheimer’s disease
por: Zhang, Ying, et al.
Publicado: (2021)

Abnormal characterization of dynamic functional connectivity in Alzheimer's disease
por: Zhao, Cui, et al.
Publicado: (2022)

An Update on Apathy in Alzheimer’s Disease
por: Dolphin, Helena, et al.
Publicado: (2023)

Induced pluripotent stem cells in Alzheimer’s disease: applications for disease modeling and cell-replacement therapy
por: Yang, Juan, et al.
Publicado: (2016)

Epigenetic modifications of chronic hypoxia-mediated neurodegeneration in Alzheimer’s disease
por: Liu, Hui, et al.
Publicado: (2014)

Rivastigmine in the treatment of Alzheimer’s disease: an update
por: Onor, Maria Luisa, et al.
Publicado: (2007)

PICALM and Alzheimer’s Disease: An Update and Perspectives
por: Ando, Kunie, et al.
Publicado: (2022)

Involvement of Huanglian Jiedu Decoction on Microglia with Abnormal Sphingolipid Metabolism in Alzheimer’s Disease
por: Qi, Yi-Yu, et al.
Publicado: (2022)

Involvement of cerebrovascular abnormalities in the pathogenesis and progression of Alzheimer’s disease: an adrenergic approach
por: Li, Song, et al.
Publicado: (2021)

APP(swe) /PS1(ΔE9) mice exhibit low oxygen saturation and alterations of erythrocytes preceding the neuropathology and cognitive deficiency during Alzheimer's disease
por: Wang, Manli, et al.
Publicado: (2023)

Metabolic Abnormalities of Erythrocytes as a Risk Factor for Alzheimer's Disease
por: Kosenko, Elena A., et al.
Publicado: (2018)

Comprehensive Management of Daily Living Activities, behavioral and Psychological Symptoms, and Cognitive Function in Patients with Alzheimer's Disease: A Chinese Consensus on the Comprehensive Management of Alzheimer's Disease
por: Jia, Jianjun, et al.
Publicado: (2021)

Alteration of Metabolic Profile and Potential Biomarkers in the Plasma of Alzheimer’s Disease
por: Shao, Yaping, et al.
Publicado: (2020)

Nanophthalmos: An Update on the Biological Parameters and Fundus Abnormalities
por: Yang, Ning, et al.
Publicado: (2021)

Alzheimer’s Disease: An Updated Overview of Its Genetics
por: Andrade-Guerrero, Jesús, et al.
Publicado: (2023)

An update on the toxicity of Aβ in Alzheimer’s disease
por: Götz, Jürgen, et al.
Publicado: (2008)

Progress update: Pharmacological treatment of Alzheimer’s disease
por: Hogan, David B
Publicado: (2007)

Current and Future Treatments in Alzheimer Disease: An Update
por: Yiannopoulou, Konstantina G, et al.
Publicado: (2020)

An update on the novel and approved drugs for Alzheimer disease
por: Alhazmi, Hassan Ahmad, et al.
Publicado: (2022)

Hyperbaric oxygen ameliorates cognitive impairment in patients with Alzheimer's disease and amnestic mild cognitive impairment
por: Chen, Jianwen, et al.
Publicado: (2020)

Targeting abnormal metabolism in Alzheimer's disease: The Drug Repurposing for Effective Alzheimer's Medicines (DREAM) study
por: Desai, Rishi J., et al.
Publicado: (2020)

The dual roles of cytokines in Alzheimer’s disease: update on interleukins, TNF-α, TGF-β and IFN-γ
por: Zheng, Cong, et al.
Publicado: (2016)

Updates on the association of brain injury and Alzheimer's disease
por: Klomparens, Kara, et al.
Publicado: (2020)

Circadian dysfunction and Alzheimer's disease – An updated review
por: Ahmad, Faizan, et al.
Publicado: (2022)

Genetics of amyotrophic lateral sclerosis: an update
por: Chen, Sheng, et al.
Publicado: (2013)

Novel Therapeutic Approaches for Alzheimer’s Disease: An Updated Review
por: Yu, Tien-Wei, et al.
Publicado: (2021)

Experimental Evidence of the Benefits of Acupuncture for Alzheimer's Disease: An Updated Review
por: Yu, Chao-Chao, et al.
Publicado: (2020)

Acrolein Induces Retinal Abnormalities of Alzheimer’s Disease in Mice
por: Wang, Shuyi, et al.
Publicado: (2023)

Cellular Senescence in Metabolic-Associated Kidney Disease: An Update
por: Gao, Pan, et al.
Publicado: (2022)

Brain metabolism in Alzheimer’s disease: biological mechanisms of exercise
por: Xu, Longfei, et al.
Publicado: (2023)

Factors Influencing Alzheimer’s Disease Risk: Whether and How They are Related to the APOE Genotype
por: Zhang, Rong, et al.
Publicado: (2022)

Hemostatic Abnormalities in COVID-19: An Update
por: Aggarwal, Mukul, et al.
Publicado: (2020)

Mechanisms of abnormal adult hippocampal neurogenesis in Alzheimer’s disease
por: Zhou, Yujuan, et al.
Publicado: (2023)

Deep brain stimulation for Alzheimer's Disease: An update
por: Aldehri, Majed, et al.
Publicado: (2018)

Lipid Metabolism Reprogramming of Immune Cells in Acne: An Update
por: Wu, Shuhui, et al.
Publicado: (2023)

Effects of Tea Catechins on Alzheimer’s Disease: Recent Updates and Perspectives
por: Ide, Kazuki, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_mvgsllf07p4poklvdtueo53hi2